These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3650926)

  • 1. [Serological survey on the prevalence of anti-HTLV-III antibodies in a psychiatric hospital].
    Antila CC; Blotta MH; Gomes MC
    Rev Paul Med; 1986; 104(6):328. PubMed ID: 3650926
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-HTLV III antibodies in the personnel of a hospital in the Campania region].
    Ferro V; Sapia P; Perna C; Salvi MP; Piscopo V
    Quad Sclavo Diagn; 1986 Mar; 22(1):104-9. PubMed ID: 3641325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies anti-HTLV III and lymphocyte subsets of high risk subjects.
    Ripa S; Mignini F; Anichini M; Casprini P; Prenna M
    Boll Ist Sieroter Milan; 1987; 66(2):101-5. PubMed ID: 3663335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of anti-HTLV-III antibodies in volunteer blood donors in Guipuzcoa].
    Cortés A; Francisco C; Larrañaga MJ; Cárdenas JM
    Med Clin (Barc); 1987 Jan; 88(1):38-9. PubMed ID: 3644127
    [No Abstract]   [Full Text] [Related]  

  • 5. Seroepidemiological survey of HIV-1 and HIV-2 antibodies in Gabon.
    Delaporte E; Dupont A; Merlin M; Josse R; Hamono B; Larouze B; Brun-Vezinet F
    AIDS; 1988 Apr; 2(2):136-7. PubMed ID: 3132942
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acquired immune deficiency syndrome in hemophiliac subjects].
    Ogata K; Sugihara T; Kamiya T; Saito H
    Rinsho Byori; 1987 Feb; 35(2):141-6. PubMed ID: 3647140
    [No Abstract]   [Full Text] [Related]  

  • 7. [Penetration of anti-LVA/HTLV-III in type A and B hemophiliacs. Clinical and immunologic follow-up].
    Ollero M; Leal M; Ramsey R; Wichman I; Vinuesa M; Muñoz J; Palmer E; Lissen E
    Med Clin (Barc); 1986 Jan; 86(3):100-4. PubMed ID: 3485746
    [No Abstract]   [Full Text] [Related]  

  • 8. [Visceral leishmaniasis associated with positive anti-HTLV III antibody].
    Verdejo J; Alvar J; Polo RM; González Lahoz JM
    Rev Clin Esp; 1987 Mar; 180(4):221. PubMed ID: 3647541
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of antibodies against HTLV-III in the at risk population in Madrid. Clinical study and incidence of virologic markers].
    González Lahoz JM; Gutiérrez Angulo MT; Polo Rodríguez R; Subirats Núñez M; Moreno Celda V; Baquero Mochales M
    Rev Clin Esp; 1987 May; 180(8):416-9. PubMed ID: 3649830
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic abnormalities and antibodies to HTLV-III in asymptomatic drug addicts.
    Ortona L; Laghi V; Tamburrini E; Nervo P; Cauda R
    Ala J Med Sci; 1987 Jan; 24(1):46-51. PubMed ID: 3644604
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of anti-HTLV-III testing of volunteer blood donors.
    Grindon AJ
    Beitr Infusionther Klin Ernahr; 1987; 18():1-5. PubMed ID: 3326580
    [No Abstract]   [Full Text] [Related]  

  • 13. [Distribution of anti-rubella virus antibodies in a female population sample of the community of Perugia and serological results of an anti-rubella vaccination experiment].
    Iorio AM; Rivosecchi P; Fanelli M; Pitzurra M
    Boll Ist Sieroter Milan; 1972; 51(5):405-9. PubMed ID: 4656955
    [No Abstract]   [Full Text] [Related]  

  • 14. HTLV-III antibodies in a patient with mycosis fungoides.
    Srivastava BI; Getchell JP; Stoll HL
    J Med; 1986; 17(1):57-63. PubMed ID: 3473157
    [No Abstract]   [Full Text] [Related]  

  • 15. Computerised anti-HTLV-III data collection and integration.
    Houston SR; Barr A
    Med Lab Sci; 1986 Oct; 43(4):340-3. PubMed ID: 3477676
    [No Abstract]   [Full Text] [Related]  

  • 16. [Detection of neutralizing antibodies against measles virus in Indians of Xingu, Central Brazil].
    Baruzzj RG; Rodrigues MC; Carvalho RP; de Souza-Dias LC
    Rev Inst Med Trop Sao Paulo; 1971; 13(5):356-62. PubMed ID: 5162259
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
    Chakrabarti S; Pradhan P; Roy A; Hira M; Bandyopadhyay G; Bhattacharya DK
    Indian J Public Health; 2006; 50(1):43-4. PubMed ID: 17193761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequency of antibodies to rotavirus in inhabitants of the city of São Paulo 1980-82].
    de Salles Gomes LF; Sakuma ME; Curti SP; Takiguti CK
    Rev Paul Med; 1983; 101(4):127-32. PubMed ID: 6320329
    [No Abstract]   [Full Text] [Related]  

  • 19. [National serological survey of dengue virus. Cuba, 1982].
    Guzmán Tirado MG; Kourí Flores G; Bravo González J; Silva LC; Vázquez Ramudo S
    Rev Cubana Med Trop; 1984; 36(2):124-31. PubMed ID: 6399591
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-ATLA (antibodies to adult T-cell leukemia-associated antigen) in the East coast of Kii Peninsula].
    Ucida T; Kobayashi T; Matsuoka N; Shimizu N; Furuta I; Katayama N; Koh T; Kita K; Tanaka I; Minami N
    Rinsho Ketsueki; 1985 Oct; 26(10):1608-13. PubMed ID: 3879293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.